select by year: all years - 2025 - 2024 - 2023 - 2022 - 2021 - 2020 - 2019 - 2018 - 2017 - 2016 - 2015 - 2014 - 2013 - 2012 - 2011 - 2010 - 2009 - 2008 - 2007 - 2006 - 2005 - 2004 - 2003 - 2002 - 1997

select by group: all groups - Sattler - Tetko - Niessing - Reif - Hagn - Zeidler - Popowicz - Alderson

Wilhelm A, Flynn C, Hammer E, Roessler J, Haller B, Napieralski R, Leuthner M, Tosheska S, Knoops K, Mathew A, Ciarimboli G, Kranich J, Flaskamp L, King S, Gevensleben H, Emslander Q, Pastucha A, Reisbeck M, Rief L, Bronger H, Dreyer T, Bausch AR, Pichlmair A, Brocker T, Zeidler R, Hammerschmidt W, Piedavent-Salomom M, López-Iglesias C, Schricker G, Haydn O, Kiechle M, Grill S, Heeren R, Knolle PA, Wilhelm O, Höchst B (2025)
Two-dimensional analysis of plasma-derived extracellular vesicles to determine the HER2 status in breast cancer patients.
Breast cancer research : BCR, Issue 1, Vol. 27, 107
DOI: 10.1186/s13058-025-02056-z, PubMed: 40524202

Kaeuferle T, Zwermann M, Stoll N, Ferrada-Ernst P, Jablonowski L, Zeidler R, Willier S, Stenger D, Yassin A, Stripecke R, Feuchtinger T (2025)
All-in-one CRISPR/Cas-engineered glucocorticoid-receptor knock-out EBV-gp350-CAR knock-in T cells are potent and resistant to dexamethasone.
Experimental hematology & oncology, Issue 1, Vol. 14, 40
DOI: 10.1186/s40164-025-00631-w, PubMed: 40108708

Luo J, Molbay M, Chen Y, Horvath I, Kadletz K, Kick B, Zhao S, Al-Maskari R, Singh I, Ali M, Bhatia HS, Minde DP, Negwer M, Hoeher L, Calandra GM, Groschup B, Su J, Kimna C, Rong Z, Galensowske N, Todorov MI, Jeridi D, Ohn TL, Roth S, Simats A, Singh V, Khalin I, Pan C, Arús BA, Bruns OT, Zeidler R, Liesz A, Protzer U, Plesnila N, Ussar S, Hellal F, Paetzold J, Elsner M, Dietz H, Erturk A (2025)
Nanocarrier imaging at single-cell resolution across entire mouse bodies with deep learning.
Nature biotechnology
DOI: 10.1038/s41587-024-02528-1, PubMed: 39809933